According to the research report, the opportunity in the global CBCT market was worth US$407.5 million in 2014. However, analysts predict that the valuation of this market will be worth US$960.8 million by 2023.

According to the research report, the Europe molecular diagnostics market was valued at US$ 1.6 billion in 2014 and is estimated to reach US$ 4.2 billion by 2023 at a CAGR of 11.4% from 2015 to 2023.